HUTCHMED (China) HCM
NASDAQ HCM
$12.63 +0.07 (+0.56%)
At close: Aug 21, 2026 · 4:00 PM EDT

HUTCHMED (China) (HCM) Change in Account Payables (2015 - 2021)

HUTCHMED (China) (HCM) posted quarterly Change in Account Payables of -$3.0 million for Q1 2021, down 156.77% year-over-year from $5.2 million in Q1 2020, and down 156.77% quarter-over-quarter from -$1.2 million in Q1 2020.

HUTCHMED (China) (HCM) Change in Account Payables (2015 - 2021) Analysis & Trends

HUTCHMED (China) (HCM) has reported Change in Account Payables for 4 consecutive years, with -$3.0 million the latest figure, recorded in Q1 2021.

  • In Q1 2021, Change in Account Payables fell 156.77% year-over-year to -$3.0 million; the TTM figure through Jun 2016 stood at $4.5 million (changed N/A YoY), while the FY2024 annual figure was $6.2 million, up 119.03% from the prior year.
  • Change in Account Payables slipped to -$3.0 million in Q1 2021 per HCM's latest filing, from -$1.2 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at -$1.2 million in Q1 2020 and bottomed at -$3.0 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn -
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn -53.00 Mn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn -143.74 Mn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn -
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn -21.20 Mn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn -
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - -
10 HUTCHMED (China) 2.19 Bn 2.19 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2021 -2.98 Mn
Mar 31, 2021 -2.98 Mn
Mar 31, 2020 -1.16 Mn
Mar 31, 2020 -1.16 Mn
Jun 30, 2016 4.55 Mn
Jun 30, 2016 4.55 Mn
Dec 31, 2015 3.52 Mn
Dec 31, 2015 3.52 Mn